The results differ significantly by administration route: topical serum, topical post-microneedling, and supervised subcutaneous injection produce different outcomes, with injectable 503A compounded GHK-Cu producing the most consistent and comprehensive results in clinical settings
Emerging as a promising treatment of rheumatoid arthritis as well, a landmark case published in Annals of the Rheumatic Diseases in 2024 described how a CD19-directed CAR-T infusion induced deep remission in a patient with polyrefractory rheumatoid arthritis, eliminating autoantibodies and restoring clinical function
MSCs can differentiate into osteocytes, chondrocytes, and adipocytes [284]
I added 0.25 mg BPC-157 daily and GHK-Cu at 0.1 mg three times weekly while continuing my Retatrutide at the 8mg dose
To compare injections to oral supplements, you can check out our blog